Quia Pharma AB (publ) (STO:QUIA)

Chuy's Holdings Statistics

Total Valuation

Quia Pharma AB has a market cap or net worth of SEK 6.68 million. The enterprise value is 7.18 million.

Market Cap	6.68M
Enterprise Value	7.18M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Quia Pharma AB has 1.97 billion shares outstanding. The number of shares has increased by 1,173.14% in one year.

Current Share Class	1.97B
Shares Outstanding	1.97B
Shares Change (YoY)	+1,173.14%
Shares Change (QoQ)	+282.23%
Owned by Insiders (%)	15.89%
Owned by Institutions (%)	0.27%
Float	1.37B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.53
PB Ratio	0.56
P/TBV Ratio	33.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.22
EV / Sales	15.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16, with a Debt / Equity ratio of 0.04.

Current Ratio	0.16
Quick Ratio	0.12
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-51.57

Financial Efficiency

Return on equity (ROE) is -245.84% and return on invested capital (ROIC) is -35.39%.

Return on Equity (ROE)	-245.84%
Return on Assets (ROA)	-28.35%
Return on Invested Capital (ROIC)	-35.39%
Return on Capital Employed (ROCE)	-114.79%
Revenue Per Employee	230,000
Profits Per Employee	-16.69M
Employee Count	2
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.75% in the last 52 weeks. The beta is 0.44, so Quia Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-91.75%
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	43.14
Average Volume (20 Days)	20,248,108

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Quia Pharma AB had revenue of SEK 460,000 and -33.38 million in losses. Loss per share was -0.04.

Revenue	460,000
Gross Profit	332,000
Operating Income	-13.67M
Pretax Income	-33.38M
Net Income	-33.38M
EBITDA	-11.49M
EBIT	-13.67M
Loss Per Share	-0.04

Balance Sheet

The company has 2,000 in cash and 500,000 in debt, giving a net cash position of -498,000 or -0.00 per share.

Cash & Cash Equivalents	2,000
Total Debt	500,000
Net Cash	-498,000
Net Cash Per Share	-0.00
Equity (Book Value)	11.90M
Book Value Per Share	0.01
Working Capital	-5.35M

Cash Flow

Operating Cash Flow	-10.17M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	72.17%
Operating Margin	-2,970.65%
Pretax Margin	-7,256.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Quia Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,173.14%
Shareholder Yield	n/a
Earnings Yield	-499.54%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 1, 2023. It was a reverse split with a ratio of 0.01.

Last Split Date	Aug 1, 2023
Split Type	Reverse
Split Ratio	0.01

Scores

Quia Pharma AB has an Altman Z-Score of -3.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.07
Piotroski F-Score	3